CRISPR Therapeutics appoints Phuong Khanh Morrow, M.D., as Chief Medical Officer effective May 23, 2022

CRISPR Therapeutics AG

Dr. Morrow brings over a decade of global drug development experience, most recently as VP at Amgen leading hematology/oncology.
She will lead CRISPR Therapeutics' global clinical development and regulatory operations.
CEO Samarth Kulkarni cited her expertise in oncology and track record in bringing novel medicines to patients.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.